Literature DB >> 11124247

The costs of HIV/AIDS care at government hospitals in Zimbabwe.

K Hansen1, G Chapman, I Chitsike, O Kasilo, G Mwaluko.   

Abstract

According to official figures, HIV infection in Zimbabwe stood at 700 000-1 000 000 in 1995, representing 7-10% of the population, with even higher expected numbers in 2000. Such high numbers will have far reaching effects on the economy and the health care sector. Information on costs of treatment and care of HIV/AIDS patients in health facilities is necessary in order to have an idea of the likely costs of the increasing number of HIV/AIDS patients. Therefore, the present study estimated the costs per in-patient day as well as per in-patient stay for patients in government health facilities in Zimbabwe with special emphasis on HIV/AIDS patients. Data collection and costing was done in seven hospitals representing various levels of the referral system. The costs per in-patient day and per in-patient stay were estimated through a combination of two methods: bottom-up costing methodology (through an in-patient note review) to identify the direct treatment and diagnostic costs such as medication, laboratory tests and X-rays, and the standard step-down costing methodology to capture all the remaining resources used such as hospital administration, meals, housekeeping, laundry, etc. The findings of the study indicate that hospital care for HIV/AIDS patients was considerably higher than for non-HIV/AIDS patients. In five of the seven hospitals visited, the average costs of an in-patient stay for an HIV/AIDS patient were found to be as much as twice as high as a non-HIV/AIDS patient. This difference could be attributed to higher direct costs per in-patient day (medication, laboratory tests and X-rays) as well as longer average lengths of stay in hospital for HIV/AIDS patients compared with non-infected patients. Therefore, the impact on hospital services of increasing number of HIV/AIDS patients will be enormous.

Entities:  

Mesh:

Year:  2000        PMID: 11124247     DOI: 10.1093/heapol/15.4.432

Source DB:  PubMed          Journal:  Health Policy Plan        ISSN: 0268-1080            Impact factor:   3.344


  9 in total

1.  The state of health economic and pharmacoeconomic evaluation research in Zimbabwe: A review.

Authors:  Paul Gavaza; Karen Rascati; Carolyn Brown; Kenneth Lawson; Teresa Mann
Journal:  Curr Ther Res Clin Exp       Date:  2008-06

2.  Brief communication: economic comparison of opportunistic infection management with antiretroviral treatment in people living with HIV/AIDS presenting at an NGO clinic in Bangalore, India.

Authors:  K R John; Nirmala Rajagopalan; K V Madhuri
Journal:  MedGenMed       Date:  2006-11-01

3.  Basing care reforms on evidence: the Kenya health sector costing model.

Authors:  Steffen Flessa; Michael Moeller; Tim Ensor; Klaus Hornetz
Journal:  BMC Health Serv Res       Date:  2011-05-27       Impact factor: 2.655

4.  Virological outcomes and risk factors for non-suppression for routine and repeat viral load testing after enhanced adherence counselling during viral load testing scale-up in Zimbabwe: analytic cross-sectional study using laboratory data from 2014 to 2018.

Authors:  Trudy Tholakele Mhlanga; Richard Makurumidze; Bart K M Jacobs; Tom Decroo; Emma Govere; Hilda Bara; Prosper Chonzi; Ngwarai Sithole; Tsitsi Apollo; Wim Van Damme; Simbarashe Rusakaniko; Lutgarde Lynen
Journal:  AIDS Res Ther       Date:  2022-07-09       Impact factor: 2.846

5.  Hospital Bed Occupancy and HIV/AIDS in three Major Public Hospitals of Addis Ababa, Ethiopia.

Authors:  Melesse Tamiru; Jemal Haidar
Journal:  Int J Biomed Sci       Date:  2010-09

6.  Capacity utilization and the cost of primary care visits: implications for the costs of scaling up health interventions.

Authors:  Taghreed Adam; Steeve Ebener; Benjamin Johns; David B Evans
Journal:  Cost Eff Resour Alloc       Date:  2008-11-13

7.  Setting priorities for the health care sector in Zimbabwe using cost-effectiveness analysis and estimates of the burden of disease.

Authors:  Kristian Schultz Hansen; Glyn Chapman
Journal:  Cost Eff Resour Alloc       Date:  2008-07-28

8.  Econometric estimation of country-specific hospital costs.

Authors:  Taghreed Adam; David B Evans; Christopher JL Murray
Journal:  Cost Eff Resour Alloc       Date:  2003-02-26

9.  The economic burden of visceral leishmaniasis in Sudan: an assessment of provider and household costs.

Authors:  Filip Meheus; Abuzaid A Abuzaid; Rob Baltussen; Brima M Younis; Manica Balasegaram; Eltahir A G Khalil; Marleen Boelaert; Ahmed M Musa
Journal:  Am J Trop Med Hyg       Date:  2013-11-04       Impact factor: 2.345

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.